Royalty Report: Medical, Diagnostic, Device – Collection: 7331


Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 5


This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 5

Primary Industries

  • Medical
  • Diagnostic
  • Device
  • Disease
  • Instruments
  • Surgical
  • Test/Monitoring

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 7331

License Grant
The Licensor has entered into a development contract and License Agreement for our prothrombin blood clotting measuring device with the  Scottish Licensee.

Under the Agreement with the Licensee, the Licensor will grant an exclusive, worldwide License for the use of technology to produce and market a prothrombin blood clotting measuring device.

License Property
Non-Invasive Blood Analyte Measurement Products

The development contract contributes over $2 million, over an 18-month period, and culminates in the delivery of the initial batch of units for market launch during calendar year 2005.

The prothrombin time test belongs to a group of blood tests that assess the clotting ability of blood. The test is also known as the pro time or PT test.

Field of Use
The monitor is the first in a series of applications that measures the content and characteristics of blood through the use of the Hall Effect, a well-known physics phenomenon that can be used to measure the change in magnetic fields – the spaces in which magnetic forces are detectable; created by magnetostrictive ultrasonic scalers to cause the tips of instruments such as ultrasonic scalers to vibrate.

Prothrombin is used by patients undergoing warfarin/coumadin anticoagulation therapy after a heart attack or stroke to ensure that drug levels are maintained at optimum levels.

Prothrombin blood clotting measuring device is a minimally-invasive, accurate and safe, characteristic measuring device for heart attack and stroke sufferers.

IPSCIO Record ID: 5895

License Grant
The Licensor and Licensee together developed the prothrombin measurement device or 'PT Device'.
License Property
Prothrombin, a glycoprotein formed by and stored in the liver and present in the blood plasma that is converted to thrombin in the presence of thromboplastin and calcium ion during blood clotting. Also called factor II.
Field of Use
The prothrombin measurement device is used for the measurement of coagulation of blood in patients at risk of heart disease and stroke.

IPSCIO Record ID: 406

License Grant
Licensor grants to Licensee an option to purchase a license to make, use and sell devices incorporating Licensor's Technology for use in blood glucose measurement applications devices and total hemoglobin measurement applications devices for marketing or other distribution directly to, and only for use in, hospitals.  Such license shall be exclusive for the earlier of three (3) years following the date that such devices are ready for sale in such market, or four (4) years from the date that Licensor makes the technology available to Licensee.  Thereafter, this license shall be nonexclusive.  Such license shall include the right to sell such devices on an OEM basis (excluding companies in glucose monitoring business) to no more than two OEM companies at any one time.
Field of Use
Licensee desires an option to purchase a license to technology  developed by LABS for use in blood glucose monitoring applications in the  hospital market.

IPSCIO Record ID: 203255

License Grant
The University Licensor grants to the Licensee a nonexclusive license to make, have made on its behalf, use, offer to sell or sell, offer to lease or lease, import, or otherwise offer to dispose or dispose of Licensed Products in the Territory.
License Property
The Product is for a biomarker relating to warfarin sensitivity for use in a Warfarin Sensitivity Test.

Warfarin sensitivity testing (genotyping) may be used to help determine someone's likely sensitivity or, less commonly, resistance to warfarin and to help select appropriate doses. Warfarin is an anticoagulant, a drug that is prescribed to help prevent inappropriate blood clotting (thrombosis and thromboembolism) in people who are at risk, or to help keep an existing blood clotting condition from getting worse.

Field of Use
The use is for the Human clinical diagnostics field, including Research Use Only (RUO), lnvestigation Use Only, (IUO), Analyte Specific Reagents (ASR), and In Vitro Diagnostic (!VD) fields of use for anticoagulant dosing.

Licensee is a molecular diagnostics company focused on developing and commercializing our eSensor detection technology.

IPSCIO Record ID: 211915

License Grant
Licensor hereby grants to Licensee an exclusive, worldwide, right and license to practice the Patent Rights and Know-How in the Field of Use to make, have made, develop, improve, use, promote, market and sell Sensors and Instruments, including the right to have third parties manufacture, sell and distribute on behalf of Licensee.
License Property
The licensed property are such patents and applications relating to a method and device for taking measurements in the alimentary canal region between the stomach and the mouth, or in the respiratory canal region between the lungs and face, including mouth and nasal regions, to assess or help assess systemic hypoperfusion.

Sensor as used in this Agreement means any device which detects signals either in or around
(1) the alimentary canal between the stomach and the mouth;
(2) the mouth;
(3) the nasal passages; or
(4) the respiratory region between the lungs and face (nose/mouth), to assess or help assess systemic hypoperfusion and that is covered by a validly issued U.S. patent included in the Patent Rights. Sensors can be disposable or reusable, and shall not include any part of an Instrument, which may connect to the Sensor to process electrical or optical signals from the Sensor.

Field of Use
Field of Use means applications for taking measurements in the alimentary canal region between the stomach and the mouth, or in the respiratory canal region between the lungs and face (including mouth and nasal regions) to assess or help assess systemic hypoperfusion, and specifically excludes all Field Forward Military Applications and all other applications not directly related to taking measurements in the alimentary and respiratory regions referred to herein to assess or help assess systemic hypoperfusion (e.g., measurements for regional tissue perfusion of any internal organ, appendage, etc.).
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.